Immuno Cellular Therapeutics is categorized under Medical Research in Calabasas, CA .
Immuno Cellular Therapeutics was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Andrew Gengos, Chief Executive Officer at the company’s headquarters by writing to 23622 Calabasas Road # 300, Calabasas, California CA 91302 or by phoning (818) 264-2300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Immuno Cellular Therapeutics |
| Contact Person: | Andrew Gengos, Chief Executive Officer |
| Address: | 23622 Calabasas Road # 300, Calabasas, California 91302 |
| Phone Number: | (818) 264-2300 |
| Website Address: | imuc.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417115 |
| Share This Business: |
Immuno Cellular Therapeutics was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Andrew Gengos, Chief Executive Officer for inquiries that concern Immuno Cellular Therapeutics by calling the company number (818) 264-2300, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Immuno Cellular Therapeutics can be found at the coordinates 34.155452,-118.64384 as well as the street address 23622 Calabasas Road # 300 in Calabasas, California 91302.
For its online presence, you may visit Immuno Cellular Therapeutics’s website at imuc.com and engage with its social media outlets through on Twitter and on Facebook.